Join the club for FREE to access the whole archive and other member benefits.

Giovanna Mallucci

Founding Principal Investigator at Altos Labs

Giovanna Mallucci is Centre Director of the UK DRI at the University of Cambridge, where she is the van Geest Professor of Clinical Neurosciences. Her pioneering, paradigm-shifting work on common pathogenic mechanisms in neurodegeneration has been instrumental in changing our approach to understanding and treating dementia.  Her discoveries around the role of the unfolded protein response (UPR) and its pharmacological manipulation in these disorders were hailed as a “turning point in search for medicines to control and prevent Alzheimer’s”. More recently, her lab has pursued the understanding of mechanisms of synapse regeneration to prevent neurodegeneration, which is the focus of her UK DRI research programme.  She is an ERC Consolidator Fellow and a Fellow of the Academy of Medical Sciences. A practicing neurologist specialising in dementia, she bridges the lab and clinic and has established a new Translational Research Unit within the UK DRI at Cambridge to accelerate translation of basic research findings into patients.

Visit website: https://en.wikipedia.org/wiki/Giovanna_Mallucci

 giovanna-mallucci-929ba7241

 MallucciLab

See also: Company Altos Labs - Biotechnology company focused on cellular rejuvenation programming

Details last updated 24-Jul-2020

Giovanna Mallucci is also referenced in the following:

Altos Labs

Biotechnology company focused on cellular rejuvenation programming

Giovanna Mallucci News

Cold water swimming might help develop a new dementia therapy

BBC - 19-Oct-2020

Triggers an increase in the same protein used by hibernating animals

Read more...

Experts excited by brain wonder-drug

BBC - 20-Apr-2017

Drug may stop all neurodegenerative brain diseases, including dementia and Alzheimer’s disease. ...

Read more...